Trial · NCT00262080
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double Blind Treatment Period | STARTED | Ecallantide / Ecallantide | 36 | |
| Double Blind Treatment Period | STARTED | Placebo / Ecallantide | 36 | |
| Double Blind Treatment Period | STARTED | Ecallantide (Repeat Dose Only) | 0 | |
| Double Blind Treatment Period | COMPLETED | Ecallantide / Ecallantide | 35 | |
| Double Blind Treatment Period | COMPLETED | Placebo / Ecallantide | 36 | |
| Double Blind Treatment Period | COMPLETED | Ecallantide (Repeat Dose Only) | 0 | |
| Double Blind Treatment Period | NOT COMPLETED | Ecallantide / Ecallantide | 1 | |
| Double Blind Treatment Period | NOT COMPLETED | Placebo / Ecallantide | 0 | |
| Double Blind Treatment Period | NOT COMPLETED | Ecallantide (Repeat Dose Only) | 0 | |
| Repeat Dose Treatment Period | STARTED | Ecallantide / Ecallantide | 22 | |
| Repeat Dose Treatment Period | STARTED | Placebo / Ecallantide | 26 | |
| Repeat Dose Treatment Period | STARTED | Ecallantide (Repeat Dose Only) | 19 | |
| Repeat Dose Treatment Period | COMPLETED | Ecallantide / Ecallantide | 18 | |
| Repeat Dose Treatment Period | COMPLETED | Placebo / Ecallantide | 25 | |
| Repeat Dose Treatment Period | COMPLETED | Ecallantide (Repeat Dose Only) | 14 | |
| Repeat Dose Treatment Period | NOT COMPLETED | Ecallantide / Ecallantide | 4 | |
| Repeat Dose Treatment Period | NOT COMPLETED | Placebo / Ecallantide | 1 | |
| Repeat Dose Treatment Period | NOT COMPLETED | Ecallantide (Repeat Dose Only) | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00262080/flow